WEBVTT - SEC Sued & Class Actions Over Decongestants

0:00:00.240 --> 0:00:04.240
<v Speaker 1>A coalition representing the biggest private equity and hedge funds

0:00:04.559 --> 0:00:08.479
<v Speaker 1>is suing the Securities and Exchange Commission oversweeping new rules.

0:00:09.080 --> 0:00:12.959
<v Speaker 1>The rules will require private funds to detail quarterly fees

0:00:13.000 --> 0:00:17.160
<v Speaker 1>and expenses to investors and to perform annual audits. Firms

0:00:17.239 --> 0:00:20.720
<v Speaker 1>also will be prohibited from allowing some favorite investors to

0:00:20.800 --> 0:00:24.120
<v Speaker 1>cash out more easily than others, unless those deals are

0:00:24.160 --> 0:00:28.080
<v Speaker 1>offered to all fund investors. The coalition is asking the

0:00:28.080 --> 0:00:31.840
<v Speaker 1>Fifth Circuit Court of Appeals to vacate the rules, saying

0:00:31.880 --> 0:00:36.280
<v Speaker 1>they're arbitrary and capricious and an abuse of discretion. Joining

0:00:36.280 --> 0:00:39.120
<v Speaker 1>me is securities law expert Robert him a partner at

0:00:39.120 --> 0:00:43.400
<v Speaker 1>Tartarkrinsky and Drogan. It's a six hundred and sixty page rule.

0:00:43.560 --> 0:00:45.280
<v Speaker 1>Tell us what it provides.

0:00:45.760 --> 0:00:49.519
<v Speaker 2>The new rules that the SEC adopted were designed to

0:00:50.000 --> 0:00:54.160
<v Speaker 2>really fundamentally change the way that the private fund industry

0:00:54.600 --> 0:00:58.680
<v Speaker 2>is regulated in the United States. In its adopting release,

0:00:58.840 --> 0:01:02.120
<v Speaker 2>the SEC site they did three basic concerns that it

0:01:02.200 --> 0:01:05.520
<v Speaker 2>was trying to address, one of which was lack of

0:01:05.560 --> 0:01:10.640
<v Speaker 2>transparency in fees and charges that private funds charged to investors.

0:01:10.800 --> 0:01:14.679
<v Speaker 2>Another is conflicts of interest that the SEC was concerned

0:01:14.680 --> 0:01:18.720
<v Speaker 2>about between the advisory companies and the asset managers that

0:01:18.840 --> 0:01:22.800
<v Speaker 2>manage these funds and the investors themselves. And the third

0:01:22.959 --> 0:01:25.520
<v Speaker 2>was a lack of governance at the private fund So

0:01:25.680 --> 0:01:29.720
<v Speaker 2>in the SEC's adopting release, which is over six hundred pages,

0:01:29.840 --> 0:01:34.000
<v Speaker 2>they set out some very substantive and extensive new rules

0:01:34.000 --> 0:01:38.360
<v Speaker 2>that were designed to address these perceived shortcomings and problems

0:01:38.360 --> 0:01:39.759
<v Speaker 2>in the private fund market.

0:01:40.680 --> 0:01:43.800
<v Speaker 1>Bob, So is it because the size of the private

0:01:43.840 --> 0:01:47.000
<v Speaker 1>funds market has grown so much They now hold more

0:01:47.040 --> 0:01:51.480
<v Speaker 1>assets than commercial banks, and it's grown. According to SEC data,

0:01:51.600 --> 0:01:54.840
<v Speaker 1>gross assets under management grew one hundred and seventy one

0:01:54.960 --> 0:01:58.000
<v Speaker 1>percent from twenty twelve to twenty twenty two.

0:01:58.640 --> 0:02:02.480
<v Speaker 2>Yes, the rapid growth in the private funds market has

0:02:02.640 --> 0:02:05.840
<v Speaker 2>been one of the facts that the SEC has cited

0:02:06.040 --> 0:02:09.920
<v Speaker 2>for justification of its new rules. Right now, according to

0:02:09.960 --> 0:02:13.720
<v Speaker 2>the SEC, there's over twenty six trillion dollars in assets

0:02:13.800 --> 0:02:17.679
<v Speaker 2>under management in private funds, and the SEC used that

0:02:17.880 --> 0:02:21.560
<v Speaker 2>as one of its basis for the concerns that it's

0:02:21.560 --> 0:02:25.800
<v Speaker 2>expressed and the reason for these new extensive regulations.

0:02:26.320 --> 0:02:29.600
<v Speaker 1>This was adopted in a three to two vote along

0:02:29.720 --> 0:02:30.560
<v Speaker 1>party lines.

0:02:31.280 --> 0:02:35.120
<v Speaker 2>Yes, it's right. These new rules are very controversial, both

0:02:35.280 --> 0:02:38.160
<v Speaker 2>in the private fund industry as well as at the

0:02:38.200 --> 0:02:42.440
<v Speaker 2>Commission itself. At the time when the rules were proposed

0:02:42.480 --> 0:02:44.880
<v Speaker 2>and set for a vote at the Commission, it was

0:02:45.040 --> 0:02:48.160
<v Speaker 2>passed on a three to two vote, with two commissioners

0:02:48.720 --> 0:02:52.920
<v Speaker 2>dissenting and one of the commissioner's Commissioner Pierce, wrote a

0:02:53.080 --> 0:02:57.040
<v Speaker 2>very singing descent from the rules, saying that they were

0:02:57.080 --> 0:02:59.799
<v Speaker 2>ill conceived and that they were going to impose a

0:02:59.840 --> 0:03:04.000
<v Speaker 2>lot of costly burdens on the industry, and also criticizing

0:03:04.360 --> 0:03:07.680
<v Speaker 2>the majority of commissioners because in her view, the rules

0:03:07.720 --> 0:03:12.200
<v Speaker 2>really were not justified. Commissioner Pierce also cited the statistic

0:03:12.280 --> 0:03:15.480
<v Speaker 2>of over twenty six trillion in AUM in the industry

0:03:16.000 --> 0:03:18.560
<v Speaker 2>and said that in fact, that shows that the market

0:03:18.639 --> 0:03:22.720
<v Speaker 2>is very successful. The investors that invest in private funds

0:03:22.720 --> 0:03:27.440
<v Speaker 2>are very sophisticated institutional investors. They're advised by the world's

0:03:27.480 --> 0:03:30.720
<v Speaker 2>top law firms, and if there really was a problem

0:03:30.760 --> 0:03:33.600
<v Speaker 2>in this market, it's really hard to explain why the

0:03:33.600 --> 0:03:37.200
<v Speaker 2>private fund market would be growing so rapidly, and investors

0:03:37.200 --> 0:03:40.840
<v Speaker 2>have been enjoying significant returns and profits on their investment,

0:03:40.920 --> 0:03:44.320
<v Speaker 2>which these rules will cut into as a result of

0:03:44.080 --> 0:03:46.080
<v Speaker 2>the high cost of implementation.

0:03:47.040 --> 0:03:49.800
<v Speaker 1>These rules are watered down right from what the SEC

0:03:50.240 --> 0:03:51.240
<v Speaker 1>originally wanted.

0:03:51.600 --> 0:03:55.080
<v Speaker 2>Yes, in the proposing release that came out several months ago,

0:03:55.160 --> 0:03:59.120
<v Speaker 2>the SEC had originally proposed even more stringent rules and

0:03:59.200 --> 0:04:02.960
<v Speaker 2>stringent pro ambitions. And due to the backlash and the

0:04:02.960 --> 0:04:07.480
<v Speaker 2>comments that were submitted by investors and industry participants, the

0:04:07.520 --> 0:04:10.440
<v Speaker 2>SEC changed and when watered down some of these rules.

0:04:10.440 --> 0:04:13.200
<v Speaker 2>But the final rules were still you know, quite strong.

0:04:13.480 --> 0:04:17.120
<v Speaker 2>And I think you know what's concerned Commissioner Pierce and

0:04:17.480 --> 0:04:20.760
<v Speaker 2>others in the industry, is that really the argument here

0:04:20.839 --> 0:04:24.960
<v Speaker 2>is that the SEC overstepped its statutory authority. You know,

0:04:25.000 --> 0:04:29.960
<v Speaker 2>it's justification for adopting these new rules was based on

0:04:30.360 --> 0:04:33.359
<v Speaker 2>a provision that's the general anti fraud provision in the

0:04:33.400 --> 0:04:36.839
<v Speaker 2>Advisor's Act Statute, as well as a provision, a short

0:04:36.839 --> 0:04:39.760
<v Speaker 2>provision in dot frank that was really geared towards the

0:04:39.839 --> 0:04:46.279
<v Speaker 2>retail investors and regulating retail oriented investment funds. And the

0:04:46.320 --> 0:04:49.240
<v Speaker 2>biggest complaint of the industry they've gone to court to

0:04:49.360 --> 0:04:53.919
<v Speaker 2>challenge these rules is that the rules prohibit outright prohibit

0:04:53.960 --> 0:04:58.680
<v Speaker 2>a lot of activities and contractual terms that are very commonplace.

0:04:58.760 --> 0:05:01.839
<v Speaker 2>You know, an example of that is certain large investors

0:05:01.920 --> 0:05:06.560
<v Speaker 2>get preferred information rights, they can negotiate certain provisions with

0:05:06.640 --> 0:05:10.680
<v Speaker 2>advisors that would allow them to withdraw their funds in

0:05:10.720 --> 0:05:14.440
<v Speaker 2>a shorter lock up period than other investors. And that's

0:05:14.480 --> 0:05:18.080
<v Speaker 2>just a fundamental characteristic of the private funds market that

0:05:18.120 --> 0:05:21.880
<v Speaker 2>you can have these customized terms. But the SEC said

0:05:21.960 --> 0:05:24.479
<v Speaker 2>essentially that that can no longer happen. You can't have

0:05:24.600 --> 0:05:26.039
<v Speaker 2>negotiated terms like that.

0:05:26.640 --> 0:05:30.360
<v Speaker 1>Lead plaintiffs attorney Eugene Scalia wrote in the lawsuit quote,

0:05:30.400 --> 0:05:34.520
<v Speaker 1>the rules exceed the Commission's statutory authority, were adopted without

0:05:34.640 --> 0:05:40.000
<v Speaker 1>compliance with notice and comment requirements, and are otherwise arbitrary, capricious,

0:05:40.040 --> 0:05:43.160
<v Speaker 1>and abusive discretion and contrary to law. You got everything

0:05:43.160 --> 0:05:46.000
<v Speaker 1>in there. Did they not have notice and comment on these?

0:05:46.640 --> 0:05:49.120
<v Speaker 2>Well, they actually did have notice in comment and it

0:05:49.200 --> 0:05:53.520
<v Speaker 2>was quite quite a long and detailed notice in common procedure.

0:05:54.240 --> 0:05:57.320
<v Speaker 2>What the industry is complaining about in that particular section

0:05:57.640 --> 0:06:00.960
<v Speaker 2>is that the final rules that were adopted by the

0:06:01.000 --> 0:06:05.720
<v Speaker 2>SEC are so different than what was originally proposed. Is that,

0:06:06.040 --> 0:06:09.640
<v Speaker 2>in effect that the notice in common period was not sufficient,

0:06:10.000 --> 0:06:13.240
<v Speaker 2>and they're arguing in the industry that once the Commission

0:06:13.320 --> 0:06:15.640
<v Speaker 2>changed the rules to such a great extent they should

0:06:15.640 --> 0:06:19.400
<v Speaker 2>have undergone another notice in common period so that the

0:06:19.440 --> 0:06:22.920
<v Speaker 2>industry and others could comment on these new proposed rules

0:06:23.360 --> 0:06:27.120
<v Speaker 2>and hopefully convince the SEC to roll them back even further.

0:06:28.680 --> 0:06:33.520
<v Speaker 1>Drew Maloney, chief executive the American Investment Council, to all

0:06:33.600 --> 0:06:37.040
<v Speaker 1>the Wall Street Journal that the rules will discourage competition,

0:06:37.240 --> 0:06:42.680
<v Speaker 1>harm investors, reduce returns, stifle innovation, and impose costly burdens

0:06:42.680 --> 0:06:45.640
<v Speaker 1>on funds of all sizes. Do you agree with any

0:06:45.720 --> 0:06:45.919
<v Speaker 1>of that?

0:06:46.760 --> 0:06:49.440
<v Speaker 2>Well, I do. I think that there's no question that

0:06:49.480 --> 0:06:52.600
<v Speaker 2>the rules themselves are going to be quite costly. Even

0:06:52.640 --> 0:06:55.800
<v Speaker 2>in the adopting release, it's acknowledged by the SEC that

0:06:55.880 --> 0:06:59.000
<v Speaker 2>it's going to cost billions of dollars industry wide to

0:06:59.040 --> 0:07:01.840
<v Speaker 2>comply with the rule. In the argument is that this

0:07:02.000 --> 0:07:06.520
<v Speaker 2>really falls most heavily on the small advisors or new

0:07:06.560 --> 0:07:09.680
<v Speaker 2>advisors that want to come into the space, and essentially

0:07:09.720 --> 0:07:14.280
<v Speaker 2>the costs associated with compliance is going to be prohibitive.

0:07:14.840 --> 0:07:17.080
<v Speaker 2>But I think, you know, one of the main points

0:07:17.120 --> 0:07:19.720
<v Speaker 2>of the industry too, is that it really questions the

0:07:19.840 --> 0:07:22.920
<v Speaker 2>role of the SEC in the sense that for years,

0:07:23.200 --> 0:07:26.680
<v Speaker 2>the industry, which is made up of these institutional investors

0:07:26.680 --> 0:07:30.240
<v Speaker 2>that are very sophisticated and private fund managers have been

0:07:30.280 --> 0:07:34.400
<v Speaker 2>going along fine in terms of negotiating contract provisions that

0:07:34.480 --> 0:07:38.720
<v Speaker 2>were customized to their own individual and situations that were

0:07:38.760 --> 0:07:42.000
<v Speaker 2>structured in that in that way, and the SEC has

0:07:42.120 --> 0:07:45.160
<v Speaker 2>now stepped into the picture and said, you know, no, no,

0:07:45.480 --> 0:07:48.920
<v Speaker 2>you know, we know better as the SEC what contractual

0:07:49.000 --> 0:07:52.160
<v Speaker 2>terms should be in place, and the contractual terms that

0:07:52.720 --> 0:07:55.720
<v Speaker 2>you've been negotiating all along though, those are no longer

0:07:55.960 --> 0:07:58.720
<v Speaker 2>going to be permitted because you know, we have decided

0:07:58.760 --> 0:08:02.480
<v Speaker 2>to fundamentally change the way this market is regulated. And

0:08:02.520 --> 0:08:05.880
<v Speaker 2>the industry is saying that the SEC has no statutory

0:08:05.880 --> 0:08:09.880
<v Speaker 2>authority from Congress to step in and make that unilateral determination.

0:08:10.960 --> 0:08:16.000
<v Speaker 1>SEC chair Gary Gansler said he feels very confident in

0:08:16.120 --> 0:08:18.960
<v Speaker 1>the agency's conclusion that it does have the power to

0:08:19.000 --> 0:08:22.440
<v Speaker 1>implement the rules. What's your take on it. Does it

0:08:22.480 --> 0:08:23.160
<v Speaker 1>have the power?

0:08:23.840 --> 0:08:25.760
<v Speaker 2>I think that's going to be a tough argument for

0:08:25.840 --> 0:08:29.720
<v Speaker 2>the SEC. The industry challenged the rules in the Fifth Circuit,

0:08:29.880 --> 0:08:34.720
<v Speaker 2>which historically has been somewhat hostile to the SEC's expansive

0:08:34.920 --> 0:08:39.080
<v Speaker 2>claims of regulatory authority. So the industry, you know, made

0:08:39.120 --> 0:08:41.480
<v Speaker 2>a smart decision in terms of the forum that they've

0:08:41.520 --> 0:08:45.880
<v Speaker 2>decided to challenge these rules, and in the adopting release,

0:08:45.960 --> 0:08:49.880
<v Speaker 2>the SEC really just pointed to some very general provisions,

0:08:49.920 --> 0:08:53.400
<v Speaker 2>you know, the anti fraud provision is one basis, and

0:08:53.480 --> 0:08:57.920
<v Speaker 2>another provisions that related to requiring the SEC to provide

0:08:58.000 --> 0:09:01.880
<v Speaker 2>enhanced rulemaking so that advisors would have to be clear

0:09:02.120 --> 0:09:05.960
<v Speaker 2>about the terms and conditions of their relationship with investors,

0:09:06.040 --> 0:09:10.160
<v Speaker 2>which was contained in the retail regulation section of DoD

0:09:10.240 --> 0:09:13.640
<v Speaker 2>Frank And traditionally, federal courts in the last several years

0:09:13.679 --> 0:09:16.400
<v Speaker 2>have been hostile not only to the SEC, but to

0:09:16.440 --> 0:09:21.440
<v Speaker 2>other agencies who claim these broad ranging powers to regulate

0:09:21.480 --> 0:09:24.480
<v Speaker 2>industries that in a lot of respects are hard hard

0:09:24.520 --> 0:09:27.880
<v Speaker 2>to tie into the congressional grants of authority that have

0:09:27.920 --> 0:09:29.200
<v Speaker 2>been made to the agencies.

0:09:29.640 --> 0:09:32.720
<v Speaker 1>Coming up next, I'll continue this conversation with Robert him

0:09:33.000 --> 0:09:36.080
<v Speaker 1>and we'll talk more about why this suit was filed

0:09:36.120 --> 0:09:40.880
<v Speaker 1>at the Fifth Circuit. Lawsuits challenging the SEC rules are

0:09:40.960 --> 0:09:44.319
<v Speaker 1>filed directly to appeals court, so they skipped the lower

0:09:44.360 --> 0:09:48.160
<v Speaker 1>district court and they went to the Fifth Circuit, as

0:09:48.160 --> 0:09:51.479
<v Speaker 1>you mentioned, which is the go to venue for conservatives

0:09:51.480 --> 0:09:56.880
<v Speaker 1>and business groups challenging regulatory authority and ranging from the

0:09:56.920 --> 0:10:01.080
<v Speaker 1>abortion pill, which is still in litigation the SEC's in

0:10:01.200 --> 0:10:01.920
<v Speaker 1>house courts.

0:10:02.720 --> 0:10:06.199
<v Speaker 2>Yes, that's correct. You know, the Fifth Circuit in particular

0:10:06.760 --> 0:10:11.800
<v Speaker 2>has been very open to constitutional based arguments from business

0:10:11.800 --> 0:10:15.560
<v Speaker 2>groups and private parties to really look at what agencies

0:10:15.640 --> 0:10:18.800
<v Speaker 2>are doing to make sure that it's it's constrained within

0:10:18.840 --> 0:10:22.840
<v Speaker 2>their statutory authority. And this is really a fundamental principle

0:10:22.840 --> 0:10:25.120
<v Speaker 2>in the Constitution in terms of you know, in the

0:10:25.320 --> 0:10:30.079
<v Speaker 2>democracy are elected representatives in Congress are supposed to make

0:10:30.360 --> 0:10:33.040
<v Speaker 2>laws that people can vote on, and then there's a

0:10:33.160 --> 0:10:37.720
<v Speaker 2>narrow delegation to agencies to implement those laws. But here,

0:10:38.160 --> 0:10:41.720
<v Speaker 2>for example, with the SEC's regulation of the industry, and

0:10:41.760 --> 0:10:45.640
<v Speaker 2>these new rules really didn't go through a democratic process.

0:10:45.720 --> 0:10:48.360
<v Speaker 2>It was just something that the agency decided, you know,

0:10:48.440 --> 0:10:52.040
<v Speaker 2>in their view, needed to be done and impose these rules.

0:10:52.080 --> 0:10:54.120
<v Speaker 2>And then that's the argument from the industry. We're We're

0:10:54.120 --> 0:10:56.040
<v Speaker 2>going to have to see if the judges in the

0:10:56.040 --> 0:10:59.160
<v Speaker 2>Fifth Circuit accept that, and that's going to be their

0:10:59.480 --> 0:11:02.120
<v Speaker 2>decision as to whether or not these SEC rules come

0:11:02.160 --> 0:11:06.040
<v Speaker 2>within the statutory authority. And the Investment Advisors Act to

0:11:06.080 --> 0:11:09.559
<v Speaker 2>allow the SEC to implement these sort of changes and rules.

0:11:10.280 --> 0:11:14.640
<v Speaker 1>It's been sort of a regulatory blitz by SEC Chair

0:11:14.800 --> 0:11:18.880
<v Speaker 1>Gary Gensler that we've talked about before. Is this just

0:11:19.040 --> 0:11:20.720
<v Speaker 1>one step too far?

0:11:21.720 --> 0:11:24.360
<v Speaker 2>Yeah, I think that that's part of the analysis. One

0:11:24.400 --> 0:11:27.840
<v Speaker 2>of the concerns that Commissioner Peerce had that the industry

0:11:27.920 --> 0:11:32.199
<v Speaker 2>has as well, is that when the SEC conducts its

0:11:32.280 --> 0:11:36.640
<v Speaker 2>statutorily require cost benefit analysis of the new rules, they

0:11:36.679 --> 0:11:39.520
<v Speaker 2>look at each rule one by one and they say,

0:11:39.600 --> 0:11:42.160
<v Speaker 2>what's the cost and the benefits of this particular rule

0:11:42.240 --> 0:11:45.200
<v Speaker 2>on the industry. But the point that the industry is

0:11:45.320 --> 0:11:47.720
<v Speaker 2>making is that that's not always the best way to

0:11:47.880 --> 0:11:51.400
<v Speaker 2>look at this, because the SEC has been engaged in

0:11:51.880 --> 0:11:54.280
<v Speaker 2>a lot of new rule making. It seems like every

0:11:54.320 --> 0:11:56.680
<v Speaker 2>week there's a new rule that comes out, and the

0:11:56.720 --> 0:11:59.240
<v Speaker 2>industry is saying that it's not sufficient just to look

0:11:59.280 --> 0:11:59.800
<v Speaker 2>one by one.

0:12:00.080 --> 0:12:01.160
<v Speaker 3>Really have to look at the.

0:12:01.120 --> 0:12:04.160
<v Speaker 2>Whole basket of rules that the SEC is coming out

0:12:04.200 --> 0:12:06.600
<v Speaker 2>with in lots of different areas, when you look at

0:12:06.600 --> 0:12:09.520
<v Speaker 2>this sort of costs that are being imposed on the

0:12:09.520 --> 0:12:12.679
<v Speaker 2>private sector and whether the rules are really going to

0:12:12.760 --> 0:12:16.120
<v Speaker 2>provide the investor protection benefits that the SEC claims that

0:12:16.160 --> 0:12:17.640
<v Speaker 2>they are working towards.

0:12:18.000 --> 0:12:22.200
<v Speaker 1>Are these cases different in that this is a really

0:12:22.440 --> 0:12:27.120
<v Speaker 1>wealthy and powerful industry that the SEC is going up against.

0:12:27.800 --> 0:12:30.200
<v Speaker 2>Well, it does make a difference in a sense that

0:12:30.360 --> 0:12:35.360
<v Speaker 2>the challenge to these rules is certainly a well funded effort.

0:12:35.720 --> 0:12:40.040
<v Speaker 2>The lead lawyer Jean Scalia, who's the son of Justice Scalia,

0:12:40.120 --> 0:12:44.200
<v Speaker 2>the lead Justice Scalia, is probably the top lawyer that

0:12:44.280 --> 0:12:48.320
<v Speaker 2>the industry is used to challenge various regulations, not just

0:12:48.360 --> 0:12:51.000
<v Speaker 2>at the SEC, but at the EPA as well on

0:12:51.080 --> 0:12:55.840
<v Speaker 2>the argument that the rules exceed statutory grants of authority.

0:12:56.480 --> 0:12:59.320
<v Speaker 2>But I think it's also a more fundamental point. The

0:12:59.360 --> 0:13:02.840
<v Speaker 2>industry is arguing that Congress deliberately set up a two

0:13:02.920 --> 0:13:08.000
<v Speaker 2>part regulatory system. One is mutual funds, which are regulated

0:13:08.120 --> 0:13:12.360
<v Speaker 2>under the Investment Company Act, which has extensive disclosures and

0:13:12.440 --> 0:13:16.880
<v Speaker 2>substantive rules that are appropriately in place to protect private

0:13:16.960 --> 0:13:22.480
<v Speaker 2>retail investors. And Congress made a conscious decision to not

0:13:22.679 --> 0:13:26.719
<v Speaker 2>impose that extensive regulatory regime on private funds which are

0:13:26.720 --> 0:13:30.360
<v Speaker 2>opened only to a very high net worth investors and

0:13:30.440 --> 0:13:34.560
<v Speaker 2>institutional investors. And Congress basically left it up to the

0:13:34.600 --> 0:13:41.120
<v Speaker 2>parties in that scenario to negotiate contractual arrangements regarding fees

0:13:41.360 --> 0:13:45.400
<v Speaker 2>regarding investment objectives and what duties the advisor owes and

0:13:45.520 --> 0:13:49.040
<v Speaker 2>what the SEC has done with these rules is blur

0:13:49.240 --> 0:13:53.080
<v Speaker 2>the distinction between those two regulatory regimes and is really

0:13:53.160 --> 0:13:57.440
<v Speaker 2>importing these extensive regulations from the mutual fund space onto

0:13:57.440 --> 0:14:01.600
<v Speaker 2>the private fund space. And a lot of respect, if there's.

0:14:01.440 --> 0:14:05.679
<v Speaker 1>An adverse ruling to the SEC, does that have implications

0:14:05.720 --> 0:14:08.520
<v Speaker 1>for other areas the SEC is regulating.

0:14:09.520 --> 0:14:12.719
<v Speaker 2>It won't have a direct implication for other rules that

0:14:12.800 --> 0:14:16.640
<v Speaker 2>the SEC is making, but in a certain sense, it

0:14:16.760 --> 0:14:20.800
<v Speaker 2>really from a practical perspective, makes the agency sit up

0:14:20.800 --> 0:14:24.560
<v Speaker 2>and take notice, to really understand that courts are going

0:14:24.600 --> 0:14:28.640
<v Speaker 2>to be scrutinizing their claims of statutory authority and perhaps

0:14:28.920 --> 0:14:32.600
<v Speaker 2>gives the SEC more reason to pause it's rulemaking and

0:14:32.640 --> 0:14:36.280
<v Speaker 2>not be so aggressive in the future with regards to

0:14:36.320 --> 0:14:39.720
<v Speaker 2>the type of rules and changes that it imposes on

0:14:39.800 --> 0:14:40.480
<v Speaker 2>the industry.

0:14:41.000 --> 0:14:44.359
<v Speaker 1>Bob was the SEC sort of prepared for this lawsuit?

0:14:44.920 --> 0:14:47.840
<v Speaker 2>The SEC really understood that they were going to have

0:14:48.200 --> 0:14:51.640
<v Speaker 2>a challenge of these rules in court, and the adopting

0:14:51.920 --> 0:14:56.240
<v Speaker 2>release has quite an extensive discussion by the SEC as

0:14:56.240 --> 0:15:00.680
<v Speaker 2>to what its claims of statutory authority are. In addition

0:15:00.720 --> 0:15:04.240
<v Speaker 2>to going through the two satchatory provisions, and the adopting release,

0:15:04.400 --> 0:15:07.520
<v Speaker 2>the SEC goes to great lengths to really try to

0:15:07.560 --> 0:15:11.960
<v Speaker 2>explain that it's not really just institutional investors that are

0:15:12.040 --> 0:15:16.200
<v Speaker 2>at stake here. The adopting release talks about that it's

0:15:16.200 --> 0:15:21.080
<v Speaker 2>it's pension funds and endowments, and indirectly those pensions are

0:15:21.080 --> 0:15:26.239
<v Speaker 2>made up of civil service workers, environment police officials, teachers,

0:15:26.320 --> 0:15:29.920
<v Speaker 2>community activists, and the SEC goes through a whole description

0:15:30.240 --> 0:15:33.880
<v Speaker 2>in their adopting release as to how these everyday types

0:15:33.920 --> 0:15:37.880
<v Speaker 2>of people are impacted by the private fund industry and

0:15:37.920 --> 0:15:41.520
<v Speaker 2>the types of rules and regulations that are imposed on it. So,

0:15:42.080 --> 0:15:44.560
<v Speaker 2>you know, the SEC knew that this challenge was coming.

0:15:45.080 --> 0:15:47.800
<v Speaker 2>They've done, you know, everything they can to prepare for it.

0:15:48.000 --> 0:15:50.680
<v Speaker 2>So it's going to be a very interesting when the

0:15:50.720 --> 0:15:54.160
<v Speaker 2>court addresses this. The parties have proposed a timeframe that

0:15:54.680 --> 0:15:57.720
<v Speaker 2>would allow the Fifth Circuit to issue ruling by May

0:15:57.880 --> 0:16:01.640
<v Speaker 2>twenty twenty four, which is several months before a lot

0:16:01.680 --> 0:16:03.880
<v Speaker 2>of the final deadline for when these rules have to

0:16:03.920 --> 0:16:04.520
<v Speaker 2>go in effect.

0:16:05.160 --> 0:16:08.400
<v Speaker 1>So a long road ahead, Thanks so much, Bob. That's

0:16:08.520 --> 0:16:12.120
<v Speaker 1>Robert him of Tartarkrinsky and Drogen. Coming up next on

0:16:12.120 --> 0:16:16.920
<v Speaker 1>the Bloomberg law show class action lawsuits against pharmaceutical companies

0:16:17.000 --> 0:16:24.160
<v Speaker 1>and retailers over ineffective decongestants. We're approaching cold and flu season,

0:16:24.200 --> 0:16:27.440
<v Speaker 1>and the Food and Drug Administration has said the leading

0:16:27.560 --> 0:16:31.680
<v Speaker 1>over the counter decongestion used by millions of Americans looking

0:16:31.720 --> 0:16:35.000
<v Speaker 1>for relief from a stuffy nose is no more effective

0:16:35.040 --> 0:16:39.440
<v Speaker 1>than a placebo. Advisors to the FDA voted unanimously last

0:16:39.480 --> 0:16:42.760
<v Speaker 1>week against the effectiveness of the key drug found in

0:16:42.880 --> 0:16:47.520
<v Speaker 1>popular versions of sudafed, day quill and other medications stocked

0:16:47.520 --> 0:16:48.680
<v Speaker 1>on store shelves.

0:16:49.320 --> 0:16:53.960
<v Speaker 4>This ingredient panel affron is in so many different cold medicines.

0:16:54.080 --> 0:16:57.200
<v Speaker 4>That's why it is important to kind of educate yourself

0:16:57.200 --> 0:17:00.000
<v Speaker 4>on what to look for and just avoid that ingredient.

0:17:00.840 --> 0:17:05.560
<v Speaker 1>Doctor Purvy Perik, an allergist at NYU Langone Health, recommends

0:17:05.600 --> 0:17:09.560
<v Speaker 1>reading the labels of these products and choosing something else instead.

0:17:09.960 --> 0:17:13.879
<v Speaker 1>It didn't take long after the FDA's announcement for several

0:17:13.960 --> 0:17:19.240
<v Speaker 1>class action lawsuits to be filed against pharmaceutical companies and retailers.

0:17:19.680 --> 0:17:22.960
<v Speaker 1>My guest is healthcare attorney Harry Nelson of Nelson Hardiman

0:17:23.680 --> 0:17:27.520
<v Speaker 1>Harry first tell us about this board of advisors and

0:17:27.800 --> 0:17:28.720
<v Speaker 1>what they decided.

0:17:29.320 --> 0:17:32.640
<v Speaker 3>Yeah, it was an FDA advisory panel that finally came

0:17:32.920 --> 0:17:35.920
<v Speaker 3>out with a statement that people studying funnelf've been talking

0:17:35.920 --> 0:17:37.800
<v Speaker 3>about for a while, which is that it is not

0:17:38.119 --> 0:17:42.760
<v Speaker 3>better than placebo. That essentially it's ineffective when taken orally.

0:17:43.359 --> 0:17:47.280
<v Speaker 3>It does not actually function as a decongestine, and little

0:17:47.280 --> 0:17:50.440
<v Speaker 3>of the drug actually reaches the nose to be a decongestine.

0:17:50.480 --> 0:17:54.080
<v Speaker 3>It's effective when it's used in a nasal pray directly

0:17:54.200 --> 0:17:56.360
<v Speaker 3>to the nose. But the problem is that we sell

0:17:56.400 --> 0:17:59.320
<v Speaker 3>billions of dollars of these different decongestin drugs where people

0:17:59.320 --> 0:18:01.639
<v Speaker 3>take it orally and it has absolutely no effect, was

0:18:01.800 --> 0:18:03.280
<v Speaker 3>completely broken down in the stomach.

0:18:03.720 --> 0:18:07.159
<v Speaker 1>So you mentioned this, But there have been decades of

0:18:07.240 --> 0:18:12.400
<v Speaker 1>studies and questions and documentation and clinical trial results. Why

0:18:12.440 --> 0:18:14.720
<v Speaker 1>did it take so long for them to come to

0:18:14.800 --> 0:18:16.200
<v Speaker 1>this conclusion.

0:18:17.200 --> 0:18:20.080
<v Speaker 3>It's a good question. It's kind of an indictment, honestly,

0:18:20.400 --> 0:18:25.200
<v Speaker 3>of the FDA's ability to do serious review. There were

0:18:25.359 --> 0:18:29.040
<v Speaker 3>studies being put forward and petitions made to re examine it.

0:18:29.080 --> 0:18:31.000
<v Speaker 3>But when you go back and look at what was happening,

0:18:31.400 --> 0:18:33.520
<v Speaker 3>you know, for the last twenty plus years, it's been

0:18:33.600 --> 0:18:37.120
<v Speaker 3>a process of rubber stamping and ignoring what's been said.

0:18:37.160 --> 0:18:39.320
<v Speaker 3>It was a glacial pace, and it took an enormous

0:18:39.320 --> 0:18:42.240
<v Speaker 3>amount of time for peer review studies to actually be

0:18:42.680 --> 0:18:44.879
<v Speaker 3>given the attention they deserve. So it's kind of an

0:18:44.920 --> 0:18:48.200
<v Speaker 3>indictment of the FDA process, you know that it took

0:18:48.280 --> 0:18:51.080
<v Speaker 3>this long to see something that was quite obvious to

0:18:51.200 --> 0:18:52.119
<v Speaker 3>people who were studying it.

0:18:52.680 --> 0:18:56.399
<v Speaker 1>And the decision is confusing to consumers because shouldn't ineffective

0:18:56.520 --> 0:19:00.320
<v Speaker 1>drugs be taken off the market and replaced? But here

0:19:00.320 --> 0:19:03.439
<v Speaker 1>they're saying, no, you don't need to throw away these products.

0:19:03.800 --> 0:19:05.919
<v Speaker 3>No one is saying these products are dangerous or the

0:19:05.960 --> 0:19:09.560
<v Speaker 3>penalleffern causes harm. They're just saying it's ineffective. It's not

0:19:09.680 --> 0:19:14.200
<v Speaker 3>better than placebo. So there's no danger associated with using

0:19:14.200 --> 0:19:17.160
<v Speaker 3>these products. They're probably just not the best choices to use.

0:19:17.680 --> 0:19:19.560
<v Speaker 3>You need an effective decongestion.

0:19:20.240 --> 0:19:24.040
<v Speaker 1>This is just an advisory opinion. The FDA doesn't have

0:19:24.200 --> 0:19:27.280
<v Speaker 1>to go along with it. And now what happens, They're

0:19:27.280 --> 0:19:29.400
<v Speaker 1>going to allow the public to comment. What good does

0:19:29.440 --> 0:19:32.120
<v Speaker 1>public comment do on an issue like this? I don't

0:19:32.119 --> 0:19:32.520
<v Speaker 1>get that.

0:19:33.280 --> 0:19:35.840
<v Speaker 3>Yeah. Also, it's a fair question. It's not at all

0:19:35.880 --> 0:19:37.800
<v Speaker 3>clear what public comment is going to add to the

0:19:37.800 --> 0:19:40.760
<v Speaker 3>conversation here. It just seems like they're still continuing to

0:19:40.800 --> 0:19:43.359
<v Speaker 3>go slower than you would hope. Once we've kind of

0:19:43.400 --> 0:19:46.120
<v Speaker 3>finally come to this public realization that there's a drug

0:19:46.160 --> 0:19:48.240
<v Speaker 3>that's not working on the market and people are spending

0:19:48.240 --> 0:19:49.800
<v Speaker 3>a lot of money on it, what does the.

0:19:49.760 --> 0:19:52.600
<v Speaker 1>FDA have to do now in addition to you know,

0:19:52.640 --> 0:19:55.480
<v Speaker 1>we mentioned the public comments, but what has to happen next.

0:19:55.800 --> 0:19:58.359
<v Speaker 3>The next step is actually formal. This was just an

0:19:58.440 --> 0:20:02.000
<v Speaker 3>advisory chanel, but the FDA has to formally review the

0:20:02.040 --> 0:20:06.320
<v Speaker 3>status of the drug and presumably revoke its approoved status

0:20:06.440 --> 0:20:08.800
<v Speaker 3>or narrow its approved status, because again, the drug is

0:20:08.920 --> 0:20:12.560
<v Speaker 3>useful when applied directly, for example, like through a nasal spray,

0:20:12.680 --> 0:20:15.639
<v Speaker 3>but at least orally to revoke the approval of the drugs.

0:20:16.720 --> 0:20:21.080
<v Speaker 1>How unusual is it that class action lawsuits were filed

0:20:21.760 --> 0:20:26.400
<v Speaker 1>within days of the FDA's announcement.

0:20:26.280 --> 0:20:28.639
<v Speaker 3>So, I mean it's almost reflective, right, There are plaint

0:20:28.640 --> 0:20:31.000
<v Speaker 3>of law firms around the countries that are basically built

0:20:31.200 --> 0:20:35.520
<v Speaker 3>to take on harm related to different drugs, and so

0:20:35.640 --> 0:20:38.120
<v Speaker 3>soon as the FDA said the drug was ineffective, it's

0:20:38.160 --> 0:20:40.520
<v Speaker 3>not a surprise that we saw the first class action

0:20:40.600 --> 0:20:42.960
<v Speaker 3>filed down in Florida. I'm sure we're going to see more.

0:20:43.280 --> 0:20:46.240
<v Speaker 3>The real question is, other than the harm to people's

0:20:46.359 --> 0:20:50.399
<v Speaker 3>wallets from spending one point seventy five billion on the drug,

0:20:50.560 --> 0:20:53.200
<v Speaker 3>what actual harm? You know, whether there were any side

0:20:53.200 --> 0:20:56.159
<v Speaker 3>effects that actually hurt anybody from Fenel effronts. There are

0:20:56.160 --> 0:20:59.000
<v Speaker 3>a lot of reports of like minor problems like swelling

0:20:59.240 --> 0:21:03.320
<v Speaker 3>or interration and itching, but I'm not aware of any

0:21:03.440 --> 0:21:06.280
<v Speaker 3>severe harm, and it's not clear what kind of damages

0:21:06.280 --> 0:21:08.359
<v Speaker 3>they are going to be beyond just the fact that

0:21:08.400 --> 0:21:10.160
<v Speaker 3>these companies were selling an ineffector drug.

0:21:11.080 --> 0:21:15.480
<v Speaker 1>Some of the complaints charged that the defendants violated consumer

0:21:15.520 --> 0:21:20.080
<v Speaker 1>protection statutes and alleged a breach of implied warranty of

0:21:20.160 --> 0:21:24.480
<v Speaker 1>merchant ability and they committed fraud, stating the defendants intentionally

0:21:24.520 --> 0:21:29.000
<v Speaker 1>and knowingly falsely concealed, suppressed, and or admitted material facts,

0:21:29.520 --> 0:21:32.080
<v Speaker 1>including us to the standard, quality or grade of the

0:21:32.119 --> 0:21:36.960
<v Speaker 1>products they marketed and sold. But if the FDA approved this,

0:21:37.600 --> 0:21:40.360
<v Speaker 1>what were the manufacturers supposed to do? Say no, the

0:21:40.440 --> 0:21:41.320
<v Speaker 1>FDA is wrong.

0:21:41.920 --> 0:21:45.040
<v Speaker 3>You know, there's been a lot of industry studies going on,

0:21:45.200 --> 0:21:48.159
<v Speaker 3>so we know that, for example, competitors of some of

0:21:48.240 --> 0:21:50.680
<v Speaker 3>the fenleft and products, like the folks that sharing plout

0:21:50.680 --> 0:21:53.719
<v Speaker 3>who were making Clereson were doing a lot of research

0:21:53.760 --> 0:21:55.879
<v Speaker 3>to show that and arguing that these drugs were ineffective.

0:21:56.080 --> 0:22:00.520
<v Speaker 3>It's an interesting question whether internally whether the manu were

0:22:00.520 --> 0:22:03.800
<v Speaker 3>doing their own research and had reason to know that

0:22:03.880 --> 0:22:06.439
<v Speaker 3>these drugs were not effective, and whether they turned a

0:22:06.440 --> 0:22:08.639
<v Speaker 3>blind eye to it. I think it's an interesting question,

0:22:08.720 --> 0:22:11.480
<v Speaker 3>and hopefully we'll learn about some of the internal process

0:22:11.720 --> 0:22:14.399
<v Speaker 3>within the pharmaceuticals and how much they were aware of

0:22:14.440 --> 0:22:16.919
<v Speaker 3>this and taking it seriously and concerned about it. But

0:22:17.080 --> 0:22:19.479
<v Speaker 3>you know, I think that still remains ahead of us.

0:22:19.920 --> 0:22:22.680
<v Speaker 1>You know, you mentioned harm to consumers and that there's

0:22:22.720 --> 0:22:25.760
<v Speaker 1>probably very little of that, so it would be limited

0:22:25.800 --> 0:22:29.639
<v Speaker 1>to economic damages, right, I mean, how would they determine

0:22:29.720 --> 0:22:32.520
<v Speaker 1>economic damages to consumers from this?

0:22:33.200 --> 0:22:35.400
<v Speaker 3>I think what's likely to happen. I mean, I don't

0:22:35.400 --> 0:22:38.119
<v Speaker 3>mean to sound cynical, but when this case gets prosecuted,

0:22:38.200 --> 0:22:40.240
<v Speaker 3>what's likely to happen is that the lawyers who brought

0:22:40.280 --> 0:22:43.720
<v Speaker 3>these cases will have a multimillion dollar pay day and

0:22:43.760 --> 0:22:47.080
<v Speaker 3>attorneys fees, and they'll be coupons, you know, for people

0:22:47.080 --> 0:22:49.120
<v Speaker 3>who can prove that they bought the drugs, but those

0:22:49.160 --> 0:22:52.840
<v Speaker 3>coupons will be for insignificant amounts. The big winners in

0:22:52.880 --> 0:22:55.200
<v Speaker 3>this class accent are likely to be the lawyers who

0:22:55.200 --> 0:22:57.440
<v Speaker 3>get tens of millions of dollars for filing it.

0:22:57.480 --> 0:23:02.360
<v Speaker 1>As an example, Johnson and Johnson's consumer unit settle claims

0:23:02.359 --> 0:23:07.320
<v Speaker 1>alleging aerosol products contained benzene for one point seventy five

0:23:07.400 --> 0:23:11.840
<v Speaker 1>million dollars plus two point five million in attorneys fees,

0:23:12.400 --> 0:23:16.119
<v Speaker 1>So more an attorney's fees than in the settlement for consumers.

0:23:16.760 --> 0:23:17.000
<v Speaker 4>Yeah.

0:23:17.000 --> 0:23:18.879
<v Speaker 3>So a lot of people, and including me, think it

0:23:19.200 --> 0:23:21.720
<v Speaker 3>is a defect in our class action systems that, you know,

0:23:21.720 --> 0:23:24.960
<v Speaker 3>the plane of class action lawyers are motivated to bring

0:23:25.240 --> 0:23:28.520
<v Speaker 3>cases that really don't do much to advance the public interest,

0:23:28.720 --> 0:23:32.399
<v Speaker 3>but to produce profitable work for them. Kind of a

0:23:32.880 --> 0:23:36.280
<v Speaker 3>sort of bug in our class action system that anytime

0:23:36.280 --> 0:23:37.960
<v Speaker 3>there's a drug, even if the harm to the public

0:23:38.000 --> 0:23:40.359
<v Speaker 3>is really miniscule, the plane of class action lawyers have

0:23:40.400 --> 0:23:41.240
<v Speaker 3>a big opportunity.

0:23:41.480 --> 0:23:44.800
<v Speaker 1>Are those kinds of suits mostly settled? Do any of

0:23:44.800 --> 0:23:45.919
<v Speaker 1>them ever go to trial?

0:23:46.520 --> 0:23:48.760
<v Speaker 3>This is certainly not a case that's going to trial.

0:23:48.840 --> 0:23:52.159
<v Speaker 3>This is clearly you know, if there were big damages

0:23:52.680 --> 0:23:56.360
<v Speaker 3>and significant amounts that would be at risk, Like if

0:23:56.359 --> 0:23:59.240
<v Speaker 3>the harm caused by a final effort was so significant,

0:23:59.400 --> 0:24:01.600
<v Speaker 3>then there would be something to fight over and a

0:24:01.600 --> 0:24:04.680
<v Speaker 3>lot at stakes. But you know, the money that the

0:24:04.760 --> 0:24:07.000
<v Speaker 3>drug companies are likely to pay for this is going

0:24:07.080 --> 0:24:09.320
<v Speaker 3>to be something like a rounding error for them. This

0:24:09.400 --> 0:24:10.960
<v Speaker 3>is not going to be one of those multi billion

0:24:11.000 --> 0:24:14.120
<v Speaker 3>dollar settlements. You know, it's likely that the plans class

0:24:14.160 --> 0:24:16.440
<v Speaker 3>ection layers will kind of have a get in quick,

0:24:16.800 --> 0:24:19.159
<v Speaker 3>you know, reach the settlements, and the drug companies will

0:24:19.160 --> 0:24:21.600
<v Speaker 3>be offered numbers that will motivate them to do so.

0:24:21.800 --> 0:24:23.320
<v Speaker 3>I think it's a pretty safe bet that we're never

0:24:23.359 --> 0:24:26.280
<v Speaker 3>going to see a trial on the marketing of fenel efern.

0:24:27.080 --> 0:24:28.200
<v Speaker 3>Does the FDA.

0:24:28.000 --> 0:24:32.960
<v Speaker 1>Give the drug manufacturers time to put new products on

0:24:33.040 --> 0:24:36.360
<v Speaker 1>the shelves or don't they take that into consideration.

0:24:37.119 --> 0:24:41.040
<v Speaker 3>The first decision is whether to actually revoke the marketing

0:24:41.080 --> 0:24:44.160
<v Speaker 3>approval for it. But if the FDA imposes a recall,

0:24:44.400 --> 0:24:47.359
<v Speaker 3>the recall is focused on exclusively on the public health

0:24:47.880 --> 0:24:52.040
<v Speaker 3>issues and not on whether these drug companies have time

0:24:52.080 --> 0:24:55.119
<v Speaker 3>to find alternatives. That's really the drug companies problems. I'm

0:24:55.160 --> 0:24:57.200
<v Speaker 3>sure that the folks at all the companies that we're

0:24:57.200 --> 0:25:00.280
<v Speaker 3>selling sele An Efferns are you know, already working hard

0:25:00.320 --> 0:25:03.040
<v Speaker 3>on that. But the really interesting question here is whether

0:25:03.520 --> 0:25:07.320
<v Speaker 3>the fact that the drug is ineffective, though not seemingly dangerous,

0:25:07.760 --> 0:25:11.840
<v Speaker 3>is going to provoke an actual recall or alternatively, whether

0:25:12.240 --> 0:25:15.600
<v Speaker 3>presumably its sales will decline. The drug companies will obviously

0:25:15.640 --> 0:25:18.200
<v Speaker 3>stop marketing it because you know, now that the FDA

0:25:18.200 --> 0:25:20.000
<v Speaker 3>has come out with this, it's a much higher risk

0:25:20.000 --> 0:25:22.199
<v Speaker 3>for them to engage in any marketing suggesting that it

0:25:22.240 --> 0:25:25.040
<v Speaker 3>has positive benefit, and whether we'll just fade away from

0:25:25.200 --> 0:25:27.840
<v Speaker 3>the shelves of our drug stores sort of more naturally.

0:25:27.800 --> 0:25:30.840
<v Speaker 1>I sort of assume that the FGA, in light of this,

0:25:31.119 --> 0:25:34.000
<v Speaker 1>would take these off the shelves at some point, since

0:25:34.359 --> 0:25:36.360
<v Speaker 1>the best you can say is they're ineffective.

0:25:36.720 --> 0:25:40.159
<v Speaker 3>Honestly, I think the reason that tenneleffernd became popular in

0:25:40.160 --> 0:25:43.679
<v Speaker 3>the first place was because of problems associated with a

0:25:43.680 --> 0:25:47.720
<v Speaker 3>different decontestant that is effective, which is a related drug

0:25:47.760 --> 0:25:50.760
<v Speaker 3>category called pseudofhedriant. You know, more than fifteen years ago

0:25:50.760 --> 0:25:55.240
<v Speaker 3>we started seeing that metam fetamine dealers or manufacturers were

0:25:55.680 --> 0:25:59.760
<v Speaker 3>using due to Fedrian to make illegal drugs and so

0:26:00.000 --> 0:26:04.439
<v Speaker 3>so that led to the popularity of penalleffern as an alternative.

0:26:04.480 --> 0:26:06.199
<v Speaker 3>So I think now it's kind of back to the

0:26:06.280 --> 0:26:09.359
<v Speaker 3>drawing board of actually figuring out what are going to

0:26:09.400 --> 0:26:12.680
<v Speaker 3>be you know, effective decongestion, And it's going to be

0:26:12.760 --> 0:26:17.000
<v Speaker 3>interesting to see what the impact on pseudofedrian access is,

0:26:17.520 --> 0:26:20.639
<v Speaker 3>given that it is a ineffective the congestion, but also

0:26:21.119 --> 0:26:23.359
<v Speaker 3>a drug that is at risk of a view. That's

0:26:23.359 --> 0:26:24.760
<v Speaker 3>a part of the story that we haven't really been

0:26:24.800 --> 0:26:27.000
<v Speaker 3>talking about yet. But I think it is clear that

0:26:27.200 --> 0:26:30.680
<v Speaker 3>part of the rise of seneffrine was about the problems

0:26:30.720 --> 0:26:33.760
<v Speaker 3>associated with pseudophedrin. So it's going to be interesting to

0:26:33.800 --> 0:26:37.200
<v Speaker 3>see what medications are the winners after senal eleftferm phades

0:26:37.200 --> 0:26:37.720
<v Speaker 3>from the market.

0:26:38.560 --> 0:26:41.679
<v Speaker 1>Thanks so much, Harry. That's healthcare attorney Harry Nelson of

0:26:41.760 --> 0:26:42.680
<v Speaker 1>Nelson Hardiman